Pillar Biosciences appoints Dr. Eric Lai to its Board of Directors
NATICK, Mass. & SHANGHAI–(BUSINESS WIRE)–Pillar Biosciences, an innovative next-generation sequencing (NGS) solutions in-vitro diagnostics (IVD) company, today announced the appointment of Eric Lai, Ph.D. to the Board of Directors. Dr. Lai brings more than 20 years of experience in drug and IVD molecular diagnostic development to the team at Pillar Biosciences. Dr. Lai was previously […]